Gilead's $21 billion purchase of Immunomedics boosts ADC field

Tuesday, September 15, 2020 - 17:10 in Mathematics & Economics

The acquisition expands the big biotech's oncology portfolio into solid tumors

Read the whole article on C&EN

More from C&EN

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net